An enterprise Diaproph was found in 1992 at the basis of Gromashevsky Research Development Institute of Epidemiology & Infectious diseases the scientific research centre of Ukraine dealing with problems of control of infectious diseases. The main activities of Diaproph were to establish, development and production of the state-of-the art diagnostic kits for detection of the most actual infectious diseases. In 1996 the enterprise was reorganized into a scientific industrial enterprise Diaproph Med. The scientific industrial enterprise Diagraph Med is a modern immunobiotechnological company specializing on development and production of test kits based on enzymelinked immunosorbent assay (ELISA) method for diagnostics of different human and animal infectious diseases. The continuous research, technology improvement, highly skilled personnel and production and technical base allowed the company to realize a complete cycle of production and release of quality in vitro diagnostic devices meeting customer's demands. Research and development of diagnostic test kits and their components based on genetic engineering, hybridome and other modern technologies. Production of ELISA test kits, biological and chemical reagents (purified native and recombinant proteins, monoclonal and polyclonal antibodies, HRP conjugates, chromogens, affine sorbets etc.)Servicing and technical support of diagnostic laboratories, trainings and seminarsConsulting for the good laboratory practice and the development of quality system for laboratory diagnosticsTechnology transferringSupport of social projects
  • Transaction level
  • Transactions
    -
  • Response Rate
    Hidden
Business Type
Manufacturer
Location
Ukraine
Main ProductsTotal Employees
51 - 100 People
Total Annual Revenue
US$2.5 Million - US$5 Million
Year Established
1992
Certifications(1)Product Certifications
-
Patents
-
Trademarks
-
Main Markets

PRODUCT CAPACITY

Factory Information

Factory Size
1,000-3,000 square meters
Factory Location
Kyiv
No. of Production Lines
3
Contract Manufacturing
OEM Service OfferedDesign Service OfferedBuyer Label Offered
Annual Output Value
US$5 Million - US$10 Million

R&D CAPACITY

Certification

Picture
Certification Name
Certified By
Business Scope
Available Date
Verified
ISO13485
MDC
Design, development, manufacturing and sale of in-vitro diagnostic test kits and reagents for laboratory diagnostics.
2019-04-01 ~ 2022-03-31
Verified

Research & Development

21 - 30 People

TRADE CAPABILITIES

Main Markets & Product(s)

Main Markets
Total Revenue(%)
Main Product(s)
Verified
Eastern Europe
30.00%
Western Europe
30.00%
Africa
10.00%
Southern Europe
10.00%
Northern Europe
10.00%
Mid East
10.00%
Verified

Trade Ability

No. of Employees in Trade Department
11-20 People
Total Annual Revenue
US$2.5 Million - US$5 Million